The estimated Net Worth of Seed Farm, Inc. Stine is at least $22.1 Million dollars as of 16 November 2011. Seed Stine owns over 2,142,857 units of Lumos Pharma Inc stock worth over $22,062,192 and over the last 13 years Seed sold LUMO stock worth over $0.
Sign up
Seed Stine LUMO stock SEC Form 4 insiders trading
Seed has made over 1 trades of the Lumos Pharma Inc stock since 2011, according to the Form 4 filled with the SEC. Most recently Seed bought 2,142,857 units of LUMO stock worth $14,999,999 on 16 November 2011.
The largest trade Seed's ever made was buying 2,142,857 units of Lumos Pharma Inc stock on 16 November 2011 worth over $14,999,999. On average, Seed trades about 2,142,857 units every 0 days since 2011. As of 16 November 2011 Seed still owns at least 6,197,245 units of Lumos Pharma Inc stock.
You can see the complete history of Seed Stine stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Seed Stine's mailing address?
Seed's mailing address filed with the SEC is 22555 LAREDO TRAIL, , ADEL, IA, 50003.
Insiders trading at Lumos Pharma Inc
Over the last 13 years, insiders at Lumos Pharma Inc have traded over $6,087,405 worth of Lumos Pharma Inc stock and bought 2,157,996 units worth $15,106,881 . The most active insiders traders include Seed Farm, Inc. Stine, Paul R Edick, and Charles J. Jr. Link. On average, Lumos Pharma Inc executives and independent directors trade stock every 257 days with the average trade being worth of $694,335. The most recent stock trade was executed by James E Deerfield Mgmt Iii,... on 6 January 2021, trading 151,723 units of LUMO stock currently worth $3,425,905.
What does Lumos Pharma Inc do?
lumos pharma is an clinical stage biotechnology company focused on developing therapeutics for rare diseases
What does Lumos Pharma Inc's logo look like?
Complete history of Seed Stine stock trades at Lumos Pharma Inc
Lumos Pharma Inc executives and stock owners
Lumos Pharma Inc executives and other stock owners filed with the SEC include:
-
Richard J. Hawkins,
CEO & Chairman -
Dr. John C. McKew Ph.D.,
Chief Scientific Officer & Pres -
Carl W. Langren,
Consultant -
Bradley J. Powers J.D.,
Chief Compliance Officer & Gen. Counsel -
Eddie L. Varnado M.B.A.,
VP of Fin. & Corp. Controller -
Eddie L. Varnado,
VP of Fin. & Corp. Controller -
Dr. David B. Karpf B.A., M.D.,
Chief Medical Officer -
Aaron Schuchart B.B.A., CPA, M.B.A.,
Chief Bus. Officer -
Lisa Miller,
Sr. Director of Investor Relations -
Lori D. Lawley CPA,
CFO & Principal Accounting Officer -
Seed Farm, Inc. Stine,
10% owner -
Charles J. Jr. Link,
Chairman of the Board & CEO -
Nicholas N. Vahanian,
Pres, Chief Medical Officer -
Gordon H Jr Link,
Chief Financial Officer -
Paul R Edick,
Director -
Joseph Saluri,
Director -
Ernest Iii Talarico,
Director -
David J. Lundquist,
Director -
Kenneth Lynn,
Exec VP of Bus Development -
Thomas A. Raffin,
Director -
Sarah Alexander,
Director -
William J. Ramsey,
Quality Assurance Officer -
James E Deerfield Mgmt Iii,...,